105396-59-6 Usage
Description
(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-(4-methylpiperazin-1-yl)-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl ace is a complex organic molecule with a unique and detailed chemical structure. It contains hydroxy, methoxy, and methyl groups, as well as a piperazine moiety. (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-(4-methylpiperazin-1-yl)-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl ace also features a benzofurophenoxazin core and an epoxypentadeca[1,11,13]trienoazeno substructure. Due to its complex structure and functional groups, this molecule likely possesses a broad range of potential biological and pharmaceutical activities.
Uses
Used in Pharmaceutical Industry:
(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-(4-methylpiperazin-1-yl)-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl ace is used as a potential pharmaceutical agent for various applications due to its complex structure and functional groups. Its hydroxy and methoxy groups may enable interactions with biopolymers and macromolecules, making it a promising candidate for the development of new drugs.
Used in Research and Development:
This complex organic molecule is also used in research and development for understanding its potential biological activities and exploring its applications in various fields. The presence of the epoxypentadeca[1,11,13]trienoazeno substructure and the benzofurophenoxazin core may provide unique properties and functionalities that can be harnessed for the development of new materials and technologies.
Used in Drug Delivery Systems:
(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-(4-methylpiperazin-1-yl)-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl ace can be employed in drug delivery systems to improve the efficacy and bioavailability of pharmaceutical agents. Its complex structure and functional groups may allow for the development of novel drug delivery systems that can enhance the therapeutic outcomes of various treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 105396-59-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,3,9 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 105396-59:
(8*1)+(7*0)+(6*5)+(5*3)+(4*9)+(3*6)+(2*5)+(1*9)=126
126 % 10 = 6
So 105396-59-6 is a valid CAS Registry Number.
105396-59-6Relevant articles and documents
Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins
Li, Jing,Ma, Zhenkun,Chapo, Katrina,Yan, Dalai,Lynch, A. Simon,Ding, Charles Z.
, p. 5510 - 5513 (2007)
We report herein the preparation and anti-staphylococcal activity of a series of novel 11-deoxy-11-hydroxyiminorifamycins. Many of the compounds synthesized exhibit potent activity against wild-type Staphylococcus aureus with MICs equivalent to, or better